Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children

被引:4
|
作者
Katlan, Banu [1 ]
Kesici, Selman [2 ]
Karacanoglu, Dilek [1 ]
Oygar, Pembe Derin [3 ]
Yuksekgonul, Ayse Unal [4 ]
Sener, Seher [5 ]
Aykan, Hayrettin Hakan [4 ]
Ozsurekci, Yasemin [3 ]
Ozen, Seza [5 ]
Bayrakci, Benan [2 ]
机构
[1] Hacettepe Univ, Dept Pediat Crit Care Med, Ankara, Turkey
[2] Hacettepe Univ, Life Support Practice & Res Ctr, Ankara, Turkey
[3] Hacettepe Univ, Dept Pediat Infect Dis, Ankara, Turkey
[4] Hacettepe Univ, Dept Pediat Cardiol, Ankara, Turkey
[5] Hacettepe Univ, Dept Pediat Rheumatol, Ankara, Turkey
关键词
children; intensive care unit; plasma exchange; SARS-CoV-2; severe MIS-C; KAWASAKI-DISEASE;
D O I
10.1002/jca.21971
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Multisystem inflammatory syndrome in children (MIS-C) can be life threatening in severe cases because of uncontrolled inflammation and multi-organ failure. In this study, we report the effect of plasma exchange in the treatment of MIS-C and to emphasize the effect of its early application on outcome. Method In this retrospective observational study, the medical records of children with severe MIS-C admitted to pediatric intensive care unit (PICU) between April 2020 and January 2021 were reviewed. Severe MIS-C patients were treated according to protocol consisting of plasma exchange (PE), intravenous immune globulin, steroids, and anakinra which we called the "PISA" protocol referring to the initials. The patients were divided into two groups as early plasma exchange (E-PE) and late plasma exchange (L-PE) according to the elapse time between hospital admission and the administration of PE. Groups were compared in terms of outcome variables. Primary study outcome was 28-day mortality. Secondary outcome variables were acute phase response time, length of immunomodulatory treatment, frequency of patients requiring mechanical ventilation (MV) and inotropic support, length of inotropic support and MV, length of hospital and PICU stays. Results Eighteen pediatric patients with MIS-C were included in the study. Seventeen (95%) of the patients presented with decompensated shock and required inotropic support. One of the 17 patients needed extracorporeal membrane oxygenation support (ECMO) PISA protocol was used in all patients. There was no mortality in the E-PE group while the mortality rate was 20% in the L-PE group. Acute phase reactant response was faster in the E-PE group and immunomodulatory treatments could be reduced earlier; the frequency of patients requiring inotropic and mechanical ventilation (MV) support was lower in the E-PE group; the duration of inotropic support, duration of MV, and length of stay in hospital and PICU were significantly shorter in the E-PE group. Conclusion We suggest that in selected cases, timely administration of PE is a beneficial rescue therapy for MIS-C related hyperinflammation presenting with severe cardiovascular collapse.
引用
收藏
页码:281 / 291
页数:11
相关论文
共 50 条
  • [31] Multisystem Inflammatory Syndrome in Children: A Review
    Shields, Kerry
    Atlas, Kristin
    Farber, Jessica Strohm
    Lebet, Ruth
    AMERICAN JOURNAL OF NURSING, 2021, 121 (05) : 26 - 37
  • [32] Therapy for Multisystem Inflammatory Syndrome in Children
    Ouldali, Naim
    Belot, Alexandre
    Angoulvant, Francois
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (13):
  • [33] Acute and late echocardiographic and cardiac MRI findings in multisystem inflammatory syndrome in children
    Sirico, Domenico
    Basso, Alessia
    Reffo, Elena
    Cavaliere, Annachiara
    Castaldi, Biagio
    Sabatino, Jolanda
    Meneghel, Alessandra
    Martini, Giorgia
    Da Dalt, Liviana
    Zulian, Francesco
    Di Salvo, Giovanni
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [34] Treatment of multisystem inflammatory syndrome in children
    Tong, Tong
    Jin, Yi-Hua
    Wang, Min
    Gong, Fang-Qi
    WORLD JOURNAL OF PEDIATRICS, 2024, 20 (04) : 325 - 339
  • [35] Physiologic profile associated with severe multisystem inflammatory syndrome in children: a retrospective study
    Fabio Savorgnan
    Alvaro Moreira
    Axel Moreira
    Ananth Annapragada
    S. Kristen Sexson Tejtel
    Saul Flores
    Craig G. Rusin
    Lara Shekerdemian
    Sebastian Acosta
    Pediatric Research, 2023, 93 : 102 - 109
  • [36] Infliximab in treatment of refractory multisystem inflammatory syndrome in children with severe cardiac dysfunction
    Shankar, Guruprasad Hassan
    Oswal, Jitendra S.
    Sarangi, Bhakti U.
    Walimbe, Ajay
    Markal, Prithvichandra
    Badarayan, Karthik, V
    INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (02) : 166 - 169
  • [37] Acute and late echocardiographic and cardiac MRI findings in multisystem inflammatory syndrome in children
    Sirico, Domenico
    Basso, Alessia
    Reffo, Elena
    Cavaliere, Annachiara
    Castaldi, Biagio
    Sabatino, Jolanda
    Meneghel, Alessandra
    Martini, Giorgia
    Da Dalt, Liviana
    Zulian, Francesco
    Di Salvo, Giovanni
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [38] SEVERE MULTISYSTEM INFLAMMATORY SYNDROME IN AN ADULT WITH MYOCARDITIS
    Nwachukwu, Ifediba
    Fernandes, Mateus
    CHEST, 2021, 160 (04) : 486A - 486A
  • [39] Physiologic profile associated with severe multisystem inflammatory syndrome in children: a retrospective study
    Savorgnan, Fabio
    Moreira, Alvaro
    Moreira, Axel
    Annapragada, Ananth
    Sexson Tejtel, S. Kristen
    Flores, Saul
    Rusin, Craig G.
    Shekerdemian, Lara
    Acosta, Sebastian
    PEDIATRIC RESEARCH, 2023, 93 (01) : 102 - 109
  • [40] Pediatric Inflammatory Multisystem Syndrome or Multisystem Inflammatory Syndrome in Children: A New Thread in Pandemic Era
    Arizaga-Ballesteros, Victor
    Gutierrez-Mendoza, Marissa Andrea
    Villanueva-Sugishima, Kinoa Rina
    Santos-Guzman, Jesus
    GLOBAL PEDIATRIC HEALTH, 2021, 8